BACKGROUND: Peptide amphiphiles (PAs) are a class of amphiphilic molecules able to self-assemble into nanomaterials that have shown efficient in vivo targeted delivery. Understanding the interactions of PAs with cells and the mechanisms of their internalization and intracellular trafficking is critical in their further development for therapeutic delivery applications.
METHODOLOGY/PRINCIPAL FINDINGS: PAs of a novel, cell- and tissue-penetrating peptide were synthesized possessing two different lipophilic tail architectures and their interactions with prostate cancer cells were studied in vitro. Cell uptake of peptides was greatly enhanced post-modification. Internalization occurred via lipid-raft mediated endocytosis and was common for the two analogs studied. On the contrary, we identified the non-peptidic part as the determining factor of differences between intracellular trafficking and retention of PAs. PAs composed of di-stearyl lipid tails linked through poly(ethylene glycol) to the peptide exhibited higher exocytosis rates and employed different recycling pathways compared to ones consisting of di-palmitic-coupled peptides. As a result, cell association of the former PAs decreased with time.
CONCLUSIONS/SIGNIFICANCE: Control over peptide intracellular localization and retention is possible by appropriate modification with synthetic hydrophobic tails. We propose this as a strategy to design improved peptide-based delivery systems.
J Cell Biol. 1999 Mar 22;144(6):1271-84
[PMID:
10087269]
J Biol Chem. 2005 Jun 17;280(24):22839-46
[PMID:
15817446]
Biochemistry. 1995 Mar 21;34(11):3813-22
[PMID:
7893678]
ACS Nano. 2009 Jul 28;3(7):2007-15
[PMID:
19527019]
Science. 2002 May 3;296(5569):913-6
[PMID:
11988576]
Dev Cell. 2002 Apr;2(4):411-23
[PMID:
11970892]
J Cell Biol. 1989 Dec;109(6 Pt 1):2731-9
[PMID:
2556406]
Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9815-9
[PMID:
19487682]
Cell Motil Cytoskeleton. 2007 Mar;64(3):199-216
[PMID:
17238130]
Nat Rev Mol Cell Biol. 2009 Aug;10(8):513-25
[PMID:
19603039]
Cancer Cell. 2009 Dec 8;16(6):510-20
[PMID:
19962669]
J Phys Chem B. 2010 Oct 7;114(39):12632-40
[PMID:
20828210]
Biochemistry. 1993 Mar 30;32(12):3153-61
[PMID:
7681327]
Methods Enzymol. 2012;503:35-56
[PMID:
22230564]
FEBS Lett. 2010 May 3;584(9):1806-13
[PMID:
19925791]
Biopolymers. 2010;94(1):1-18
[PMID:
20091874]
J Cell Sci. 2001 Oct;114(Pt 20):3737-47
[PMID:
11707525]
J Cell Biol. 2009 Aug 24;186(4):615-28
[PMID:
19687251]
Nanomedicine. 2009 Mar;5(1):73-82
[PMID:
18829396]
FEMS Microbiol Lett. 2007 Jan;266(2):129-37
[PMID:
17156122]
Cell Mol Life Sci. 2001 Dec;58(14):1969-87
[PMID:
11814051]
Oncogene. 2012 Aug 16;31(33):3754-63
[PMID:
22179825]
Mol Pharm. 2010 Dec 6;7(6):2173-84
[PMID:
20822110]
J Pharm Sci. 2008 Jan;97(1):144-62
[PMID:
17763452]
Nat Rev Mol Cell Biol. 2001 Feb;2(2):107-17
[PMID:
11252952]
Langmuir. 2009 Jul 7;25(13):7279-86
[PMID:
19358585]
J Cell Biol. 2010 Mar 22;188(6):759-68
[PMID:
20231381]
J Cell Sci. 2009 Jun 1;122(Pt 11):1713-21
[PMID:
19461071]
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16157-62
[PMID:
19805273]
Biochemistry. 2009 Apr 21;48(15):3304-14
[PMID:
19245247]
Nano Lett. 2011 Sep 14;11(9):3946-50
[PMID:
21800917]
